In what U.S. FDA commissioner Stephen Hahn billed as “a major milestone” in testing for the COVID-19 pandemic, the FDA has granted an emergency use authorization (EUA) to Ellume Ltd., of East Brisbane ...
A $5 diagnostic test for COVID-19 won emergency authorization from the US Food and Drug Administration (FDA) on August 26 and could see widespread use by the end of this month. Abbott’s BinaxNOW COVID ...
CAMBRIDGE & WETHERBY, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its ...
CAMBRIDGE, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), the developer of diagnostics and innovative cancer therapies based on its proprietary Affimer® and pre|CISION™ platforms, is pleased ...
Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...
In a recent review published in Nature Reviews Bioengineering, researchers assessed the changing landscape of lateral flow tests (LFTs), and the development of next-generation LFTs based on lessons ...
A study led by Queen Mary University of London and University of Oxford has found that lateral flow tests detect Covid-19 with similar accuracy to laboratory-based PCR tests, providing they are used ...
A Covid-19 lateral flow test showing a negative result. Routine testing to identify those infected followed by efficient contact tracing, and supported isolation is still the most effective public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results